A new drug has been shown to be highly effective against pediatrics infections caused by respiratory syncytial virus (RSV).
Browsing: Infectious Diseases
A new combination of antiviral drugs did not improve clinical outcomes in hospitalized patients with severe influenza, warranting further investigation into new therapeutic strategies, according to a recent clinical trial.
Northwestern Medicine investigators continue to study the COVID-19 pandemic, from the biological mechanisms of disease and infection patterns to the pandemic’s impact on women and sexual and gender minorities.
A recent Northwestern Medicine study found global efforts to track variants grossly underreported a probable variant of concern, Eta, circulating in Nigeria in early 2021.
Respiratory syncytial virus infection during infancy results in metabolic reprogramming in epithelial cells lining the airway, according to a recent study.
Human cells use a protein named TBC1D5 to “trap and kill” influenza A viruses inside host cells, but the virus encodes its own protein to disable this defense.
Northwestern Medicine is part of the research team on a $185 million NIH project that will explore the millions of genetic variants that cause disease around the world.
Northwestern Medicine scientists continue to investigate all aspects of the COVID-19 pandemic: from molecular mechanisms of infection, to child hospitalization and single-dose vaccine response.
The Institute for Global Health (IGH) has established the Center for Pathogen Genomics and Microbial Evolution which will apply lessons learned during the COVID-19 pandemic to the tracking and prevention of future threats.
Since March 2020, a team of Northwestern Medicine scientists have been tracking the evolution of SARS- CoV-2, specifically in the city of Chicago. Their work has been pivotal in understanding how the virus spread to Chicago and what new variants have emerged in the city.